NantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell Therapy in First 35 Patients

Stock Information for NantKwest Inc.

Loading

Please wait while we load your information from QuoteMedia.